Máj- és epeúti rák: vizsgálatok itt: Németország
56 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleEndoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma
- Where
- Berlin, Bonn, Chemnitz, Essen, Hamburg, Hanover, Heidelberg, Lübeck, Ulm
- Életkor
- 18 év and over
- People
- 130
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT06175845 - 3. fázisTaking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Frankfurt am Main, Hamburg, Hanover, Heidelberg, Munich, Reutlingen
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 - No phaseTaking peopleToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
- Where
- Münster, Ulm
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06801899 - 2. fázisTaking peoplePhase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
- Where
- Aachen, Bonn, Dresden, Duesseldorf, Essen, Frankfurt am Main, Frankfurt Am Main, Giessen, Goettingen, Hamburg, Jena, Mainz, Mannheim, Munich, Oldenburg, Regensburg, Rostock, Ulm, Wesel
- Életkor
- 18 év and over
- People
- 40
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT07260175 · EU 2024-520219-42-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Berlin, Frankfurt am Main, Heidelberg
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 2. fázisTaking peopleRandomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus Bevacizumab Alone in Metastatic Colorectal Cancer Patients
- Where
- Hamburg, Hanover, Leipzig
- Életkor
- 18 év and over
- People
- 35 worldwide
- Run by
- Delcath Systems Inc.
See details and how to join2024-520356-24-00 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Aachen, Halle, Saarbrücken
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - 2. fázisTaking peopleStudy on the effect of 2 immunotherapy drugs in combination with radioactive glass spheres on the survival in liver cancer
- Where
- Berlin, Essen, Leipzig, Magdeburg, Munich
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Klinikum der Universitaet Muenchen AöR
See details and how to join2024-515127-11-00 - 2/3. fázisNot yet taking people in Németország68Ga-FAPI-46 PET for imaging of gastrointestinal cancers: A prospective interventional single-arm clinical trial (FAPI-PET-GI)
- Where
- Essen, Muenster
- Életkor
- 18 év and over
- People
- 150
- Run by
- Universitaetsklinikum Essen AöR
See details and how to join2023-506030-70-00 - 2. fázisTaking people– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases
- Where
- Amberg, Augsburg, Bad Saarow, Berlin, Bochum, Chemnitz, Duesseldorf, Essen, Esslingen am Neckar, Frankfurt am Main, Frankfurt Am Main, Halle, Hamburg, Hanover, Herne, Karlsruhe, Leipzig, Munich, Ravensburg, Schweinfurt, Trier, Ulm, Wiesbaden
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
See details and how to join2024-519929-38-00 - 1. fázisTaking peopleIs CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer?
- Where
- Heidelberg, Leipzig, Mainz
- Életkor
- 18 év and over
- People
- 154 worldwide
- Run by
- Captor Therapeutics S.A.
See details and how to join2024-511435-10-00 - No phaseTaking peopleAdjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma
- Where
- Aachen
- Életkor
- 18 év to 80 év
- People
- 30
- Run by
- RWTH Aachen University
See details and how to joinNCT04996914 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleNIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy
- Where
- Düsseldorf
- Életkor
- 18 év and over
- People
- 350
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT07365930 - 4. fázisTaking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Berlin, Tübingen
- Életkor
- 18 év to 64 év
- People
- 2076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - 4. fázisTaking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Heidelberg, Munich
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - No phaseTaking peoplePrediction of Decompensation and HCC Development in Advanced Chronic Liver Disease
- Where
- Münster
- Életkor
- 18 év and over
- People
- 600
- Run by
- University Hospital Muenster
See details and how to joinNCT06523608 - 4. fázisNot yet taking people in NémetországHOPE Against Cancer Recurrence in HCC
- Where
- Essen, Hamburg-Eppendorf, Hanover, Heidelberg, Mainz, München
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - 2. fázisTaking peopleFecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
- Where
- Augsburg, Berlin, Cologne, Essen, Heidelberg, Mannheim, Regensburg, Tuebingen, Ulm
- Életkor
- 18 év and over
- People
- 48
- Run by
- Michael Dill
See details and how to joinNCT05690048 · EU 2023-506887-15-00 - No phaseTaking peopleMultiparametric MRI for Characterization of Hepatocellular Carcinoma
- Where
- Münster
- Életkor
- 18 év and over
- People
- 128
- Run by
- University Hospital Muenster
See details and how to joinNCT06999174 - No phaseCsak meghívásosInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Hanover, Munich, Tübingen
- Életkor
- 1 nap and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseNot yet taking people in NémetországThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Cologne, Dresden, Hanover
- Életkor
- 18 év and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - 4. fázisTaking peopleTreatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
- Where
- Aachen, Augsburg, Berlin, Bochum, Bonn, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Greifswald, Halle (saale), Hanau, Hanover, Leipzig, Ludwigsburg, Mannheim, Marburg, Muenster, Munich, Nuremberg, Stuttgart, Tuebingen
- Életkor
- 18 év and over
- People
- 258
- Run by
- University of Leipzig
See details and how to joinNCT05551299 · EU 2022-500107-50-00 - No phaseTaking peopleAmplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 36
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT06821958